Home›Companies›Pluto Biosciences

Pluto Biosciences, Inc.

Updated Oct 27, 2026·Latest SEC filing May 5, 2025·Suggest an edit

About Pluto Biosciences

Pluto Biosciences is a private company based in Denver, Colorado, incorporated in 2020 in Delaware. It has reported $7,711,348 raised in three offerings on Form D since August 2021. Its chief executive is Rani Powers.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 21, 2025May 5, 2025$3,000,000fully sold5$600KEquityRule 506(b)Form D ↗
May 1, 2023May 15, 2023$3,704,373fully sold14$264KEquityRule 506(b)Form D ↗
Aug 2, 2021Aug 17, 2021$1,006,975of $1.5M target17$59,234Equity, Securities on exerciseRule 506(b)Form D ↗
Total, three offerings$7,711,348

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Pluto Biosciences's Form D filed May 5, 2025.

DW
RP
Rani Powers
CEO and director
MD
Mike Dodd
Director

Sources

  1. SECPluto Biosciences, Inc. filing history